Voglistat GM2 Tab

Tablet

Type 2 diabetes mellitus (to control post-meal blood sugar), especially as add-on therapy with diet, exercise and other antidiabetic medicines.

Voglibose is an alpha-glucosidase inhibitor that slows breakdown and absorption of carbohydrates in the intestine. This reduces the rise in blood glucose after meals and helps improve overall glycaemic control.

Tablet for oral use. Typically taken just before the start of meals (or with the first bite of food) as prescribed by the doctor. Follow diet and exercise advice; do not skip meals after taking. If a dose is missed, take with the next meal—do not double the dose.

Flatulence, abdominal pain, bloating, diarrhoea, nausea

Use with caution in patients with gastrointestinal disorders (e.g., inflammatory bowel disease, intestinal obstruction/ulceration) and in severe renal/hepatic impairment. Risk of hypoglycaemia increases when used with insulin or sulfonylureas—carry glucose (dextrose) for low sugar episodes (table sugar may act slowly). Monitor liver enzymes if advised. Not recommended in type 1 diabetes or diabetic ketoacidosis. Seek medical help for severe abdominal pain, persistent diarrhoea, jaundice or allergic reactions.

Insulin and sulfonylureas (increased risk of hypoglycaemia), other antidiabetics, digestive enzyme preparations/intestinal adsorbents (may reduce effect), corticosteroids and thiazide diuretics (may raise glucose), thyroid hormones (may alter glycaemic control)

Store below 25°C in a cool, dry place. Protect from moisture and light. Keep out of reach of children.

Voglibose tablets (various brands), Vogli 0.2 Tablet, Vobit 0.2 Tablet, Volibo 0.2 Tablet, Emglucent 0.2 Tablet